Detalles de la búsqueda
1.
Cost evaluation of continuation of therapy with dalbavancin compared to standard-of-care antibiotics alone in hospitalized persons who inject drugs with severe gram-positive infections.
Am J Health Syst Pharm
; 81(Supplement_2): S40-S48, 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38465838
Resultados
1 -
1
de 1
1
Próxima >
>>